Mesothelial cell differentiation into osteoblast- and adipocyte-like cells

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 10, 2011, Pages 2095-2105

  Lansley, Sally M ^a   Searles, Richelle G ^a   Hoi, Aina ^a   Thomas, Carla ^a,b   Moneta, Helena ^a,c   Herrick, Sarah E ^d   Thompson, Philip J ^a   Mark, Newman ^e   Sterrett, Gregory F ^a,b   Prêle, Cecilia M ^a   Mutsaers, Steven E ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Adipocyte; Bone; Cell differentiation; Epithelial to mesenchymal transition; Malignant mesothelioma; Mesothelial cell; Osteoblast; Progenitor cell; Tissue engineering

Indexed keywords

ALKALINE PHOSPHATASE; HBME 1 ANTIGEN; HBME-1 ANTIGEN; RUNX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR RUNX2; TUMOR MARKER;

ADIPOCYTE; ADIPOGENESIS; AGED; ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; EPITHELIUM; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIPID METABOLISM; MESODERM; MESOTHELIOMA; METABOLISM; MIDDLE AGED; OSTEOBLAST; PRENATAL DEVELOPMENT; RAT;

ADIPOCYTES; ADIPOGENESIS; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EPITHELIUM; GENE EXPRESSION; HUMANS; LIPID METABOLISM; MESODERM; MESOTHELIOMA; MIDDLE AGED; OSTEOBLASTS; OSTEOGENESIS; RATS; TUMOR MARKERS, BIOLOGICAL;

RATTUS;

EID: 80053266386     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01212.x     Document Type: Article

References (43)

1. Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology. 2002; 7: 171-91.
2. Herrick SE, Mutsaers SE. Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol. 2004; 36: 621-42.
3. Munoz-Chapuli R, Perez-Pomares JM, Macias D, et al. Differentiation of hemangioblasts from embryonic mesothelial cells? A model on the origin of the vertebrate cardiovascular system. Differentiation. 1999; 64: 133-41.
4. Perez-Pomares JM, Carmona R, Gonzalez-Iriarte M, et al. Origin of coronary endothelial cells from epicardial mesothelium in avian embryos. Int J Dev Biol. 2002; 46: 1005-13.
5. Perez-Pomares JM, Carmona R, Gonzalez-Iriarte M, et al. Contribution of mesothelium-derived cells to liver sinusoids in avian embryos. Dev Dyn. 2004; 229: 465-74.
6. Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int. 2003; 63: 1530-9.
7. Kawaguchi M, Bader DM, Wilm B. Serosal mesothelium retains vasculogenic potential. Dev Dyn. 2007; 236: 2973-9.
8. Wada AM, Smith TK, Osler ME, et al. Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic epicardium. Circ Res. 2003; 92: 525-31.
9. Decologne N, Kolb M, Margetts PJ, et al. TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol. 2007; 179: 6043-51.
10. Margetts PJ, Bonniaud P, Liu L, et al. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol. 2005; 16: 425-36.
11. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med. 2003; 348: 403-13.
12. Kiyozuka Y, Miyazaki H, Yoshizawa K, et al. An autopsy case of malignant mesothelioma with osseous and cartilaginous differentiation: bone morphogenetic protein-2 in mesothelial cells and its tumour. Dig Dis Sci. 1999; 44: 1626-31.
13. Klebe S, Mahar A, Henderson DW, et al. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review. Mod Pathol. 2008; 21: 1084-94.
14. Yousem SA, Hochholzer L. Malignant mesotheliomas with osseous and cartilaginous differentiation. Arch Pathol Lab Med. 1987; 111: 62-6.
15. Donna A, Betta PG. Mesodermomas: a new embryological approach to primary tumours of coelomic surfaces. Histopathology. 1981; 5: 31-44.
16. Bellows CG, Aubin JE, Heersche JN, et al. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int. 1986; 38: 143-54.
17. Foley-Comer AJ, Herrick SE, Al-Mishlab T, et al. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci. 2002; 115: 1383-9.
18. Katoh J, Ishida Y, Taniguchi H. Isolation of preadipocytes from rat adipose tissue in vitro. Folia Histochem Cytobiol. 1994; 32: 235-8.
19. Sherwood AL, Mutsaers SE, Peeva VK, et al. Spontaneously immortalized mouse mesothelial cells display characteristics of malignant transformation. Cell Prolif. 2008; 41: 894-908.
20. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 1992; 97: 493-7.
21. Demirag F, Unsal E, Tastepe I. Biphasic malignant mesothelioma cases with osseous differentiation and long survival: a review of the literature. Lung Cancer. 2007; 57: 233-6.
22. Rittinghausen S, Ernst H, Muhle H, et al. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats. Exp Toxicol Pathol. 1992; 44: 55-8.
23. Hansen O, Sim F, Marton PF, et al. Heterotopic ossification of the intestinal mesentery. Report of a case following intraabdominal surgery. Pathol Res Pract. 1983; 176: 125-30.
24. Yannopoulos K, Katz S, Flesher L, et al. Mesenteritis ossificans. Am J Gastroenterol. 1992; 87: 230-3.
25. Nakazato Y, Yamaji Y, Oshima N, et al. Calcification and osteopontin localization in the peritoneum of patients on long-term continuous ambulatory peritoneal dialysis therapy. Nephrol Dial Transplant. 2002; 17: 1293-303.
26. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant. 1998; 13: 154-9.
27. Fadare O, Bifulco C, Carter D, et al. Cartilaginous differentiation in peritoneal tissues: a report of two cases and a review of the literature. Mod Pathol. 2002; 15: 777-80.
28. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol. 1998; 76: 899-910.
29. Aubin JE. Bone stem cells. J Cell Biochem Suppl. 1998; 72: 73-82.
30. Harada H, Tagashira S, Fujiwara M, et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem. 1999; 274: 6972-8.
31. Xiao ZS, Thomas R, Hinson TK, et al. Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene. 1998; 214: 187-97.
32. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89: 747-54.
33. Stewart K, Walsh S, Screen J, et al. Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res. 1999; 14: 1345-56.
34. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat. 1995; 154: 8-20.
35. Maeda M, Johnson KR, Wheelcock MJ. Cadherin switching: essential for behavioural but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci. 2005; 118: 873-87.
36. Nasreen N, Mohammed KA, Mubarak KK, et al. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol. 2009; 297: L115-24.
37. Rodgers UR, Kevorkian L, Surridge AK, et al. Expression and function of matrix metalloproteinase (MMP)-28. Matrix Biol. 2009; 28: 263-72.
38. Tanjore H, Xu XC, Polosukhin VV, et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 2009; 180: 657-65.
39. Cheng SL, Lecanda F, Davidson MK, et al. Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation. J Bone Miner Res. 1998; 13: 633-44.
40. Simsir A, Fetsch P, Mehta D, et al. E-cadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless. Diagn Cytopathol. 1999; 20: 125-30.
41. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
42. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998; 78: 783-809.
43. Rosen ED, Walkey CJ, Puigserver P, et al. Transcriptional regulation of adipogenesis. Genes Dev. 2000; 14: 1293-307.